Latest Licensing News

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Energy World Corporation Ltd has outlined a strategic reset including a $442 million debt-to-equity conversion and is progressing towards commissioning its flagship Pagbilao LNG and power project in the Philippines, alongside advancing its Sengkang LNG facility in Indonesia.

Calix Limited has secured a pivotal $35 million joint development agreement with Rio Tinto to advance its Zesty Green Iron Demonstration Plant in Western Australia, backed by a substantial ARENA grant. This collaboration aims to pioneer low-emission steel production using innovative hydrogen and electric heating technology.

Bioxyne Limited is expanding its footprint with a new UK GMP-certified medicinal cannabis manufacturing site, backed by £850,000 in funding from South of Scotland Enterprise. This move positions the company to tap into the UK’s growing medicinal cannabis market, the second largest in Europe.

First Au Limited has completed over 4,000 metres of reverse circulation drilling at its Gimlet Gold Project, aiming to upgrade its 120,000-ounce inferred gold resource to an indicated classification. Early geological observations align with existing models, with assays pending to refine the resource estimate.

WhiteHawk Limited has launched its first Australian office in Perth and signed a Memorandum of Understanding with Novera to co-develop a cybersecurity and AI governance platform tailored for the Australian market and broader APEC region.

Prominence Energy Ltd has made significant technical progress at its Gawler Hydrogen Project, confirming high-grade natural hydrogen potential and preparing for a major geochemical survey in early 2026. The company also strengthens its global position by joining a prestigious hydrogen delegation to Korea.

Starpharma’s 2025 AGM highlighted breakthrough partnerships and clinical progress, positioning the biotech for growth. Key deals with Genentech and Radiopharm Theranostics underpin a promising pipeline and expanding revenue streams.

Kincora Copper Limited has closed a C$4 million non-brokered financing and expanded its exploration portfolio with eight active projects, advancing drilling programs alongside major partners. The company reported a net loss of CAD 2.786 million for the nine months ended September 30, 2025.

Tivan Limited has revealed promising high-grade copper and gold mineralisation from its maiden surface sampling at the Turiscai Project, marking a significant step in its Timor-Leste exploration strategy.

Besra Gold Inc. reported a $3.47 million loss for Q1 2026, weighed down by finance costs tied to a major gold purchase agreement. Despite asset impairments and net liabilities, management remains cautiously optimistic about ongoing funding and project development.

Manhattan Corporation reports exceptional 173.5 g/t gold assay from its maiden sampling at Hook Lake, Nunavut, alongside strong polymetallic results that highlight the project's vast exploration upside.